Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. John Matthew ScurlockMD & CFO | 43,91 | 4,45k | Acquisto | 101,29 | 22,28k | 0,20% |
| 2026-06-09 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -3,50k | 353,33k | Vendita | 100,95 | 23,81k | -12,82% |
| 2026-04-21 | Mr. Charles S. HyleInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 16,02k | 11,64% |
| 2026-04-22 | Ms. Laura L. WhitleyIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 9,63k | 20,98% |
| 2026-04-22 | Mr. Dale W. TremblayIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 18,00k | 10,23% |
| 2026-04-22 | Mr. Robert William StallingsInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 294,96k | 0,57% |
| 2026-04-22 | Mr. Steven P. RosenbergIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 42,38k | 4,10% |
| 2026-04-22 | Mr. Mark W. MidkiffIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 2,80k | 147,27% |
| 2026-04-22 | Ms. Elysia Holt RagusaInsider | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 18,80k | 9,75% |
| 2026-04-22 | Mr. Thomas E. LongIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 12,17k | 15,90% |
| 2026-04-22 | Mr. David S. HuntleyLead Independent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 12,47k | 15,47% |
| 2026-04-22 | Ms. Ranjana Bhattacharya ClarkIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,67k | - |
| 2026-04-22 | Mr. Jonathan E. BaliffIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 11,27k | 17,40% |
| 2026-04-22 | Ms. Paola M. ArbourIndependent Director | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 8,34k | 25,03% |
| 2026-03-11 | Ms. Paola M. ArbourIndependent Director | 1.000,00 | 91,50k | Acquisto | 91,50 | 6,67k | 17,63% |
| 2026-03-05 | Mr. Robert William StallingsInsider | 25,50k | 579,20k | Acquisto | 22,69 - 22,80 | - | - |
| 2026-03-03 | Mr. Robert William StallingsInsider | 45,00k | 1,00M | Acquisto | 22,11 - 22,51 | - | - |
| 2026-02-27 | Mr. Robert William StallingsInsider | 3,33k | 315,88k | Acquisto | 94,86 | 293,29k | 1,15% |
| 2026-02-27 | Mr. Robert William StallingsInsider | 20,00k | 444,40k | Acquisto | 22,22 | - | - |
| 2026-02-27 | SCG Ventures LPSocietà | 5,00k | 111,45k | Acquisto | 22,29 | - | - |
| 2026-02-23 | SCG Ventures LPSocietà | 40,00k | 888,00k | Acquisto | 22,14 - 22,26 | - | - |
| 2026-02-20 | Mr. Robert C. HolmesChairman, President & CEO | -1,45k | 141,17k | Derivative Exercise and Sale | 97,63 | 266,24k | - |
| 2026-02-17 | SCG Ventures LPSocietà | 10,00k | 221,28k | Acquisto | 22,11 - 22,20 | - | - |
| 2026-02-13 | Mr. Robert C. HolmesChairman, President & CEO | 6,03k | 0,00 | Derivative Exercise and Retained Stock | - | 266,24k | 2,32% |
| 2026-02-13 | Mr. Robert C. HolmesChairman, President & CEO | -3,54k | 366,11k | Derivative Exercise and Sale | 103,42 | 266,24k | - |
| 2026-02-13 | Mr. John Matthew ScurlockMD & CFO | 1,10k | 0,00 | Derivative Exercise and Retained Stock | - | 22,24k | 5,22% |
| 2026-02-13 | Mr. John Matthew ScurlockMD & CFO | -716,00 | 74,05k | Derivative Exercise and Sale | 103,42 | 22,24k | - |
| 2026-02-13 | Mr. John W. CummingsMD & COO | 891,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,13k | 7,28% |
| 2026-02-13 | Mr. John W. CummingsMD & COO | -579,00 | 59,88k | Derivative Exercise and Sale | 103,42 | 13,13k | - |
| 2026-02-13 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 773,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,31k | 2,91% |
| 2026-02-13 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -503,00 | 52,02k | Derivative Exercise and Sale | 103,42 | 27,31k | - |
| 2026-02-09 | Ellen E. DetrichController & CAO | 983,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,57k | 11,44% |
| 2026-02-09 | Ellen E. DetrichController & CAO | -390,00 | 40,80k | Derivative Exercise and Sale | 104,62 | 9,57k | - |
| 2026-02-09 | Mr. Robert C. HolmesChairman, President & CEO | 18,16k | 0,00 | Derivative Exercise and Retained Stock | - | 260,21k | 7,50% |
| 2026-02-09 | Mr. Robert C. HolmesChairman, President & CEO | -11,45k | 1,20M | Derivative Exercise and Sale | 104,62 | 260,21k | - |
| 2026-02-09 | Mr. John W. CummingsMD & COO | 3,36k | 0,00 | Derivative Exercise and Retained Stock | - | 12,24k | 37,86% |
| 2026-02-09 | Mr. John W. CummingsMD & COO | -1,08k | 113,20k | Derivative Exercise and Sale | 104,62 | 12,24k | - |
| 2026-02-09 | Mr. John Matthew ScurlockMD & CFO | 2,82k | 0,00 | Derivative Exercise and Retained Stock | - | 21,13k | 15,41% |
| 2026-02-09 | Mr. John Matthew ScurlockMD & CFO | -1,83k | 191,66k | Derivative Exercise and Sale | 104,62 | 21,13k | - |
| 2026-02-09 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 2,33k | 0,00 | Derivative Exercise and Retained Stock | - | 26,54k | 9,63% |
| 2026-02-09 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -1,53k | 159,96k | Derivative Exercise and Sale | 104,62 | 26,54k | - |
| 2026-02-04 | SCG Ventures LPSocietà | 16,89k | 360,58k | Acquisto | 21,35 - 21,36 | - | - |
| 2026-02-02 | SCG Ventures LPSocietà | 4,12k | 86,76k | Acquisto | 20,97 - 21,10 | - | - |
| 2026-01-29 | SCG Ventures LPSocietà | 7,00k | 146,45k | Acquisto | 20,91 - 20,94 | - | - |
| 2026-01-29 | Mr. John W. CummingsMD & COO | 1,06k | 0,00 | Derivative Exercise and Retained Stock | - | 8,88k | 13,51% |
| 2026-01-29 | Mr. John W. CummingsMD & COO | -442,00 | 43,70k | Derivative Exercise and Sale | 98,87 | 8,88k | - |
| 2026-01-29 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 652,00 | 0,00 | Derivative Exercise and Retained Stock | - | 24,21k | 2,77% |
| 2026-01-29 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -526,00 | 52,01k | Derivative Exercise and Sale | 98,87 | 24,21k | - |
| 2026-01-29 | Mr. David W. OmanMD & Chief Risk Officer | 722,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,39k | 43,34% |
| 2026-01-29 | Mr. David W. OmanMD & Chief Risk Officer | -584,00 | 57,74k | Derivative Exercise and Sale | 98,87 | 2,39k | - |
| 2026-01-29 | Mr. John Matthew ScurlockMD & CFO | 1,55k | 0,00 | Derivative Exercise and Retained Stock | - | 16,94k | 10,09% |
| 2026-01-29 | Mr. John Matthew ScurlockMD & CFO | -1,12k | 111,13k | Derivative Exercise and Sale | 98,87 | 16,94k | - |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | 9,20k | 0,00 | Derivative Exercise and Retained Stock | - | 242,05k | 3,95% |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | -881,00 | 86,01k | Derivative Exercise and Sale | 97,63 | 242,05k | - |
| 2026-01-29 | Mr. Robert C. HolmesChairman, President & CEO | -3,40k | 336,55k | Sale to Issuer | 98,87 | 242,05k | -1,39% |
| 2026-01-23 | Ms. Laura L. WhitleyIndependent Director | 1.000,00 | 97,54k | Acquisto | 97,51 - 97,56 | 7,96k | 14,37% |
| 2026-01-23 | SCG Ventures LPSocietà | 2,00k | 41,82k | Acquisto | 20,91 | - | - |
| 2025-11-05 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | 3,14k | 0,00 | Derivative Exercise and Retained Stock | - | 23,56k | 15,35% |
| 2025-11-05 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -2,04k | 173,42k | Derivative Exercise and Sale | 85,22 | 23,56k | - |
| 2025-10-28 | Ms. Anna M. Alvarado-PearceMD, Chief Legal Officer & Corporate Secretary | -177,00 | 0,00 | Other Disposition | - | 20,42k | -0,86% |
| 2025-10-28 | SCG Ventures LPSocietà | 5,00k | 104,15k | Acquisto | 20,83 | - | - |
| 2025-10-24 | SCG Ventures LPSocietà | 15,00k | 309,50k | Acquisto | 20,61 - 20,68 | - | - |
| 2025-07-01 | Mr. David W. OmanMD & Chief Risk Officer | 1,67k | 0,00 | Derivative Exercise and Retained Stock | - | 1,67k | - |
| 2025-07-01 | Mr. David W. OmanMD & Chief Risk Officer | -1,08k | 89,29k | Derivative Exercise and Sale | 82,60 | 1,67k | - |
| 2025-06-11 | Stallings FoundationSocietà | 10,50k | 212,94k | Acquisto | 20,28 | - | - |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
